{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Capsule+2&page=80", "query": { "intervention": "Capsule 2", "page": 80 }, "page_size": 10 }, "pagination": { "page": 80, "page_size": 10, "total_count": 5061, "total_pages": 507, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Capsule+2&page=81&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Capsule+2&page=79&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T23:33:49.580Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01163630", "title": "Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Effect of Food", "Pharmacokinetics" ], "interventions": [ { "name": "esomeprazole/ASA Fixed Dose Combination (FDC)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 24, "start_date": "2010-06", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2010-12-07", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 1, "location_summary": "Oveland Park, Kansas", "locations": [ { "city": "Oveland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01163630" }, { "nct_id": "NCT06824064", "title": "Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Colorectal Cancer", "Advanced Colorectal Cancer" ], "interventions": [ { "name": "RBS2418", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Riboscience, LLC.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2025-01-17", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-11-05", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 4, "location_summary": "Newark, Delaware • Las Vegas, Nevada • Nashville, Tennessee + 1 more", "locations": [ { "city": "Newark", "state": "Delaware" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Kingwood", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06824064" }, { "nct_id": "NCT06215430", "title": "A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Caffeine Tablet", "type": "DRUG" }, { "name": "Omeprazole capsule", "type": "DRUG" }, { "name": "Warfarin tablet", "type": "DRUG" }, { "name": "Pirtobrutinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 16, "start_date": "2021-01-11", "completion_date": "2021-04-15", "has_results": true, "last_update_posted_date": "2025-03-10", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06215430" }, { "nct_id": "NCT00508365", "title": "Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Carvedilol CR capsules", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Lisinopril", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 62, "start_date": "2007-09-25", "completion_date": "2008-06-03", "has_results": false, "last_update_posted_date": "2017-08-09", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 20, "location_summary": "Anniston, Alabama • Glendale, Arizona • Anaheim, California + 17 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00508365" }, { "nct_id": "NCT00880100", "title": "Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis", "Pancreatic Insufficiency" ], "interventions": [ { "name": "Ultrase® MT12", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "2 Years to 6 Years" }, "enrollment_count": 49, "start_date": "2009-04", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2017-03-16", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 15, "location_summary": "Aurora, Colorado • Ann Arbor, Michigan • Grand Rapids, Michigan + 11 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Syracuse", "state": "New York" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00880100" }, { "nct_id": "NCT00418600", "title": "A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Secondary Hyperparathyroidism" ], "interventions": [ { "name": "Hectorol® (doxercalciferol capsules)", "type": "DRUG" }, { "name": "doxercalciferol capsules, Hectorol®", "type": "DRUG" }, { "name": "doxercalciferol capsules, Hectorol® capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genzyme, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2006-11", "completion_date": "2007-08", "has_results": false, "last_update_posted_date": "2015-03-19", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 8, "location_summary": "Hot Springs, Arkansas • Downey, California • Tarzana, California + 5 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Tarzana", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00418600" }, { "nct_id": "NCT05545319", "title": "A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", "Coronavirus Disease 2019 (COVID-19)", "Immunocompromised", "Hospitalization", "Child, Hospitalized" ], "interventions": [ { "name": "Nirmatrelvir", "type": "DRUG" }, { "name": "Ritonavir", "type": "DRUG" }, { "name": "Placebo for nirmatrelvir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 0, "start_date": "2022-12-13", "completion_date": "2024-01-06", "has_results": false, "last_update_posted_date": "2023-03-01", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 2, "location_summary": "Cooperstown, New York • New York, New York", "locations": [ { "city": "Cooperstown", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05545319" }, { "nct_id": "NCT00527865", "title": "Single Dose Escalating Study of DAS181 in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "DAS181", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ansun Biopharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 36, "start_date": "2007-10", "completion_date": "2009-01", "has_results": false, "last_update_posted_date": "2009-01-08", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 1, "location_summary": "Miramar, Florida", "locations": [ { "city": "Miramar", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00527865" }, { "nct_id": "NCT00000892", "title": "A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Ritonavir", "type": "DRUG" }, { "name": "Nelfinavir mesylate", "type": "DRUG" }, { "name": "Levocarnitine", "type": "DRUG" }, { "name": "Adefovir dipivoxil", "type": "DRUG" }, { "name": "Saquinavir", "type": "DRUG" }, { "name": "Delavirdine mesylate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 300, "start_date": null, "completion_date": "1999-08", "has_results": false, "last_update_posted_date": "2021-11-04", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 45, "location_summary": "Birmingham, Alabama • Los Angeles, California • Menlo Park, California + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Menlo Park", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000892" }, { "nct_id": "NCT05195528", "title": "A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-Erosive Gastro-Esophageal Reflux Disease", "Heartburn" ], "interventions": [ { "name": "Vonoprazan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Phathom Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 776, "start_date": "2022-01-17", "completion_date": "2023-05-17", "has_results": true, "last_update_posted_date": "2023-12-29", "last_synced_at": "2026-11-12T23:33:49.580Z", "location_count": 108, "location_summary": "Athens, Alabama • Cullman, Alabama • Huntsville, Alabama + 94 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Cullman", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05195528" } ] }